Improving indoor air quality for a healthier home and Europe

INQUIRE

Project Description

Enabling homes to realise zero pollution holds multiple health benefits for all Europeans – especially our children. This is the goal of the EU-funded INQUIRE project. It will provide the knowledge, tools and measures needed to significantly enhance indoor air quality. Research on hazardous determinants and their sources, risk factors and effects will focus in particular on infants and young children up to 5 years old. The work will include non-invasive sampling and monitoring of over 200 homes in eight countries over the course of 1 month. Results will inform evidence-based recommendations and support beneficial exploitation by industry and policymakers.

inquire_logo

News & Events

Subscribe to our newsletter

Social media

Facebook Twitter Linkedin

INQUIRE_EU Follow

INQUIRE is a 5-year project co-funded by the European Union. This page is a focal point for the communication and dissemination of project outputs worldwide.

INQUIRE_EU
inquire_eu INQUIRE_EU @inquire_eu ·
8 Jul

☝ Under @INQUIRE_EU, various #interventions for improving #IndoorAirQuality will be tested, including air #filtration

🪟 Our partners at MANN+HUMMEL are preparing filters and air purifiers for an upcoming sampling campaign in Portugal 💪

#IAQ #health @IDEAL_CLUSTER

2

Reply on Twitter 1942466176224764154 Retweet on Twitter 1942466176224764154 1 Like on Twitter 1942466176224764154 3 Twitter 1942466176224764154
inquire_eu INQUIRE_EU @inquire_eu ·
1 Jul

➡️Our partners at @inegi_portugal have been busy characterizing #VOCs emitted from a range of consumer products

🕵Benzyl alcohol and limonene were the most frequently detected chemicals across the products tested and air fresheners were found to emit the most chemicals overall‼️

Reply on Twitter 1939934496565927979 Retweet on Twitter 1939934496565927979 Like on Twitter 1939934496565927979 Twitter 1939934496565927979
inquire_eu INQUIRE_EU @inquire_eu ·
24 Jun

🥇Prioritizing #SVOCs and #VOCs from the huge dataset for Tier II testing (@INQUIRE_EU WP3) and #insilico modelling (WP4) is a complex challenge‼️

➡️ but with our multidisciplinary team at #VITO and data science experts, we’re confident we’ll succeed🥳

Reply on Twitter 1937404070706512203 Retweet on Twitter 1937404070706512203 Like on Twitter 1937404070706512203 1 Twitter 1937404070706512203
Load More

Participants & Partners

NILU, Norway
UA, Belgium
UCAM, UK
UMU, Sweden
INEGI, Portugal
KI, Sweden
ISS, Italy
Health Board Terviseamet, Estonia
UH, Finland
SU, Sweden
JSI, Slovenia
UTARTU, Estonia
KU, Sweden
VUA, Netherlands
UOB, UK
VITO, Belgium
MU, Czech Republic
UQ, Australia
QUT, Australia
Mann+Hummel, Germany

Funding

UKRI_logo
eu_funding
NHMRC_logo

This work was co-funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10038689 and 10042425].

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

The work received funding support from the Australian National Health and Medical Research Council (NHMRC) [NHMRC; 2022/GNT2017837].